Involvement of CXC chemokine growth-related oncogene-α in monosodium urate crystal-induced arthritis in rabbits

Kazunori Fujiwara, Susumu Ohkawara, Katsumasa Takagi, Masaru Yoshinaga, Akihiro Matsukawa

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Accumulation of neutrophils is a prominent feature of gouty arthritis in which CXC chemokines may play a role. Recently, we have shown that IL-8 (CXCL8) contributes to neutrophil influx in a rabbit model of gouty arthritis. Here, we demonstrate that growth-related oncogene-α (GROα) (CXCL1), a prototype of CXC chemokine, is also involved in this process. GROα level in the joints peaked at 2 hours after intra-articular injection of monosodium urate crystals, at a time before the neutrophil influx reached the maximal level (9 hours). Once decreased, the level increased and reached the second peak at 9 hours. The kinetics was comparable to that of IL-8. Administration of anti-GROα mAb attenuated the neutrophil influx at the same level as did the anti-IL-8 IgG, and combination of these antibodies enhanced the inhibition, resulting in a 33% reduction. Interaction of GROα with TNFα, IL-1β, and IL-8 was next investigated by injecting antibodies or receptor antagonist with monosodium urate crystals. Administration of anti-TNFα mAb did not alter GROα level at 2 hours, but inhibited the levels 9 hours after the injection. Treatment with either IL-1 receptor antagonist or anti-IL-8 IgG resulted in decreased levels of GROa at 2 and 9 hours. Neutralization of GROα with anti-GROα mAb did not alter TNFα, IL-1β, and IL-8 levels at their peak (2 hours), but decreased the second peak of IL-1β (9 hours) and IL-8 (12 hours). These results provide evidence that GROα as well as IL-8 are involved ad eundem in the neutrophil infiltration in this model. IL-1 and IL-8, but not TNFα, are responsible in part for the initial phase of GROα, whereas these cytokines induce GROα in a late phase. GROα does not seem to initiate TNFα, IL-1β, and IL-8 in an early phase, but induces IL-1β and IL-8 in a late phase.

Original languageEnglish
Pages (from-to)1297-1304
Number of pages8
JournalLaboratory Investigation
Volume82
Issue number10
Publication statusPublished - Oct 2002
Externally publishedYes

Fingerprint

CXC Chemokines
Uric Acid
Interleukin-8
Oncogenes
Rabbits
Interleukin-1
Growth
Neutrophils
Gouty Arthritis
Crystal Arthropathies
Immunoglobulin G
Interleukin-9
Intra-Articular Injections
Interleukin-1 Receptors
Neutrophil Infiltration
Antibodies
Interleukin-12
Joints

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Involvement of CXC chemokine growth-related oncogene-α in monosodium urate crystal-induced arthritis in rabbits. / Fujiwara, Kazunori; Ohkawara, Susumu; Takagi, Katsumasa; Yoshinaga, Masaru; Matsukawa, Akihiro.

In: Laboratory Investigation, Vol. 82, No. 10, 10.2002, p. 1297-1304.

Research output: Contribution to journalArticle

Fujiwara, Kazunori ; Ohkawara, Susumu ; Takagi, Katsumasa ; Yoshinaga, Masaru ; Matsukawa, Akihiro. / Involvement of CXC chemokine growth-related oncogene-α in monosodium urate crystal-induced arthritis in rabbits. In: Laboratory Investigation. 2002 ; Vol. 82, No. 10. pp. 1297-1304.
@article{ba3f37c886854cc89a33bbaa9f81a790,
title = "Involvement of CXC chemokine growth-related oncogene-α in monosodium urate crystal-induced arthritis in rabbits",
abstract = "Accumulation of neutrophils is a prominent feature of gouty arthritis in which CXC chemokines may play a role. Recently, we have shown that IL-8 (CXCL8) contributes to neutrophil influx in a rabbit model of gouty arthritis. Here, we demonstrate that growth-related oncogene-α (GROα) (CXCL1), a prototype of CXC chemokine, is also involved in this process. GROα level in the joints peaked at 2 hours after intra-articular injection of monosodium urate crystals, at a time before the neutrophil influx reached the maximal level (9 hours). Once decreased, the level increased and reached the second peak at 9 hours. The kinetics was comparable to that of IL-8. Administration of anti-GROα mAb attenuated the neutrophil influx at the same level as did the anti-IL-8 IgG, and combination of these antibodies enhanced the inhibition, resulting in a 33{\%} reduction. Interaction of GROα with TNFα, IL-1β, and IL-8 was next investigated by injecting antibodies or receptor antagonist with monosodium urate crystals. Administration of anti-TNFα mAb did not alter GROα level at 2 hours, but inhibited the levels 9 hours after the injection. Treatment with either IL-1 receptor antagonist or anti-IL-8 IgG resulted in decreased levels of GROa at 2 and 9 hours. Neutralization of GROα with anti-GROα mAb did not alter TNFα, IL-1β, and IL-8 levels at their peak (2 hours), but decreased the second peak of IL-1β (9 hours) and IL-8 (12 hours). These results provide evidence that GROα as well as IL-8 are involved ad eundem in the neutrophil infiltration in this model. IL-1 and IL-8, but not TNFα, are responsible in part for the initial phase of GROα, whereas these cytokines induce GROα in a late phase. GROα does not seem to initiate TNFα, IL-1β, and IL-8 in an early phase, but induces IL-1β and IL-8 in a late phase.",
author = "Kazunori Fujiwara and Susumu Ohkawara and Katsumasa Takagi and Masaru Yoshinaga and Akihiro Matsukawa",
year = "2002",
month = "10",
language = "English",
volume = "82",
pages = "1297--1304",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Involvement of CXC chemokine growth-related oncogene-α in monosodium urate crystal-induced arthritis in rabbits

AU - Fujiwara, Kazunori

AU - Ohkawara, Susumu

AU - Takagi, Katsumasa

AU - Yoshinaga, Masaru

AU - Matsukawa, Akihiro

PY - 2002/10

Y1 - 2002/10

N2 - Accumulation of neutrophils is a prominent feature of gouty arthritis in which CXC chemokines may play a role. Recently, we have shown that IL-8 (CXCL8) contributes to neutrophil influx in a rabbit model of gouty arthritis. Here, we demonstrate that growth-related oncogene-α (GROα) (CXCL1), a prototype of CXC chemokine, is also involved in this process. GROα level in the joints peaked at 2 hours after intra-articular injection of monosodium urate crystals, at a time before the neutrophil influx reached the maximal level (9 hours). Once decreased, the level increased and reached the second peak at 9 hours. The kinetics was comparable to that of IL-8. Administration of anti-GROα mAb attenuated the neutrophil influx at the same level as did the anti-IL-8 IgG, and combination of these antibodies enhanced the inhibition, resulting in a 33% reduction. Interaction of GROα with TNFα, IL-1β, and IL-8 was next investigated by injecting antibodies or receptor antagonist with monosodium urate crystals. Administration of anti-TNFα mAb did not alter GROα level at 2 hours, but inhibited the levels 9 hours after the injection. Treatment with either IL-1 receptor antagonist or anti-IL-8 IgG resulted in decreased levels of GROa at 2 and 9 hours. Neutralization of GROα with anti-GROα mAb did not alter TNFα, IL-1β, and IL-8 levels at their peak (2 hours), but decreased the second peak of IL-1β (9 hours) and IL-8 (12 hours). These results provide evidence that GROα as well as IL-8 are involved ad eundem in the neutrophil infiltration in this model. IL-1 and IL-8, but not TNFα, are responsible in part for the initial phase of GROα, whereas these cytokines induce GROα in a late phase. GROα does not seem to initiate TNFα, IL-1β, and IL-8 in an early phase, but induces IL-1β and IL-8 in a late phase.

AB - Accumulation of neutrophils is a prominent feature of gouty arthritis in which CXC chemokines may play a role. Recently, we have shown that IL-8 (CXCL8) contributes to neutrophil influx in a rabbit model of gouty arthritis. Here, we demonstrate that growth-related oncogene-α (GROα) (CXCL1), a prototype of CXC chemokine, is also involved in this process. GROα level in the joints peaked at 2 hours after intra-articular injection of monosodium urate crystals, at a time before the neutrophil influx reached the maximal level (9 hours). Once decreased, the level increased and reached the second peak at 9 hours. The kinetics was comparable to that of IL-8. Administration of anti-GROα mAb attenuated the neutrophil influx at the same level as did the anti-IL-8 IgG, and combination of these antibodies enhanced the inhibition, resulting in a 33% reduction. Interaction of GROα with TNFα, IL-1β, and IL-8 was next investigated by injecting antibodies or receptor antagonist with monosodium urate crystals. Administration of anti-TNFα mAb did not alter GROα level at 2 hours, but inhibited the levels 9 hours after the injection. Treatment with either IL-1 receptor antagonist or anti-IL-8 IgG resulted in decreased levels of GROa at 2 and 9 hours. Neutralization of GROα with anti-GROα mAb did not alter TNFα, IL-1β, and IL-8 levels at their peak (2 hours), but decreased the second peak of IL-1β (9 hours) and IL-8 (12 hours). These results provide evidence that GROα as well as IL-8 are involved ad eundem in the neutrophil infiltration in this model. IL-1 and IL-8, but not TNFα, are responsible in part for the initial phase of GROα, whereas these cytokines induce GROα in a late phase. GROα does not seem to initiate TNFα, IL-1β, and IL-8 in an early phase, but induces IL-1β and IL-8 in a late phase.

UR - http://www.scopus.com/inward/record.url?scp=0036800235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036800235&partnerID=8YFLogxK

M3 - Article

C2 - 12379764

AN - SCOPUS:0036800235

VL - 82

SP - 1297

EP - 1304

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 10

ER -